Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 23;11(8):797-804.
doi: 10.1093/stcltm/szac040.

Cancer Stem Cells and Cell Cycle Genes as Independent Predictors of Relapse in Non-small Cell Lung Cancer: Secondary Analysis of a Prospective Study

Valentina Masciale  1   2 , Federico Banchelli  3 , Giulia Grisendi  2 , Roberto D'Amico  3 , Antonino Maiorana  4 , Alessandro Stefani  1 , Uliano Morandi  1 , Franco Stella  5 , Massimo Dominici  2 , Beatrice Aramini  1   5
Affiliations

Cancer Stem Cells and Cell Cycle Genes as Independent Predictors of Relapse in Non-small Cell Lung Cancer: Secondary Analysis of a Prospective Study

Valentina Masciale et al. Stem Cells Transl Med. .

Abstract

Purpose: Cancer stem cells (CSCs) are described as resistant to chemotherapy and radiotherapy. It has been shown that CSCs influence disease-free survival in patients undergoing surgery for lung cancer (NCT04634630). We recently described an overexpression of CSCs recurrence-related genes (RG) in lung cancer. This study aims to investigate CSC frequency and RG expression as predictors of disease-free survival in lung cancer.

Experimental design: This secondary analysis of a prospective cohort study involved 22 surgical tumor specimens from 22 patients harboring early (I-II) and locally advanced (IIIA) stages ACL and SCCL. Cell population frequency analysis of ALDHhigh (CSCs) and ALDHlow (cancer cells) was performed on each tumor specimen. In addition, RG expression was assessed for 31 target genes separately in ALDHhigh and ALDHlow populations. CSCs frequency and RG expression were assessed as predictors of disease-free survival by Cox analysis.

Results: CSCs frequency and RG expression were independent predictors of disease-free survival. CSC frequency was not related to disease-free survival in early-stage patients (HR = 0.84, 95%CI = 0.53-1.33, P = .454), whereas it was a risk factor for locally advanced-stage patients (HR = 1.22, 95%CI = 1.09-1.35, P = .000). RG expression-if measured in CSCs-was related to a higher risk of recurrence (HR = 1.19, 95%CI = 1.03-1.39, P = .021). The effect of RG expression measured in cancer cells on disease-free survival was lower and was not statistically significant (HR = 1.12, 95%CI = 0.94-1.33, P = .196).

Conclusions: CSCs frequency and RG expression are independent predictors of relapse in lung cancer. Considering these results, CSCs and RG may be considered for both target therapy and prognosis.

Keywords: cancer stem cells; cell cycle progression; cell cycle progression score; non-small cell lung cancer; recurrence.

PubMed Disclaimer

Figures

Graphical Abstract
Graphical Abstract
See this image and copyright information in PMC

References

    1. Phi LTH, Sari IN, Yang YG, et al. . Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment. Stem Cells Int. 2018;2018:5416923. 10.1155/2018/5416923 - DOI - PMC - PubMed
    1. Kim Y, Joo KM, Jin J, Nam DH.. Cancer stem cells and their mechanism of chemo-radiation resistance. Int J Stem Cells. 2009;2(2):109-114. 10.15283/ijsc.2009.2.2.109 - DOI - PMC - PubMed
    1. Ayob AZ, Ramasamy TS.. Cancer stem cells as key drivers of tumour progression. J Biomed Sci. 2018;25(1):20. 10.1186/s12929-018-0426-4 - DOI - PMC - PubMed
    1. Aramini B, Masciale V, Grisendi G, et al. . Dissecting tumor growth: the role of cancer stem cells in drug resistance and recurrence. Cancers (Basel). 2022;14(4):976. 10.3390/cancers14040976 - DOI - PMC - PubMed
    1. Masciale V, Grisendi G, Banchelli F, et al. . Isolation and identification of cancer stem-like cells in adenocarcinoma and squamous cell carcinoma of the lung: a pilot study. Front Oncol. 2019;9:1394. 10.3389/fonc.2019.01394 - DOI - PMC - PubMed

Publication types

MeSH terms

Associated data